Jaguar Health Inc (JAGX) 銘柄情報

So, when is the next RS?

Doing a chart review and JAGX showed up as one
of the 'movers'. Got my attention since I sold out before
they cratered on the failed PH 3...

So doing a little digging last night and it appears the
PH 3 had some success in at least one category of cancer.
And that they are talking to the FDA about this subsest.

If this plays out as its 'possible'?? Could they get approved
for at least this subset?? If the report of less than a million
shares is accurate? Could be a nice pop and an explanation
for why its making some noise the last several days.

Hmm disclaimer: own none... but curious.

But now Jaguar Health currently has just 674 K shares outstanding🚀🚀🚀

Sorry to hear that. The reverse/splits are an abomination and never seem to bring anything worthwhile to bulls.

76484$ I have put in this scam, everytime a new RS 🤮and now I have 999$ left, I will keep them till OOOOOOOO$

JAGX: effective March 24,2025 a one for 25 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php

This management is abysmal and embarrassing. Not even a PR to explain this, just hiding behind an 8k. Don't give a crap about their shareholders. And their Board is ok with this?

It's crazy

This one and $MULN love to RS every few months

Series J Preferred Stock? Are these getting reverse split too?

Series J Preferred Stock is not entitled to vote, on an as-converted basis and in the aggregate with respect to any shares of Common Stock and preferred stock of the Company beneficially owned by such holder and any Affiliates or Attribution Parties (as such terms are defined in the Certificate of Designation of Series J Preferred Stock) of such holder, more than 9.99% of the Company’s outstanding shares of Common Stock as of the applicable record date.

The final results for the votes regarding each proposal are set forth below.

1.
Proposal to approve an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding voting common stock, par value $0.0001 per share, at a ratio of not less than 1-for-15 and not greater than 1-for-40, with the exact ratio, if approved and effected at all, to be set within that range at the discretion of the Company’s board of directors and publicly announced by the Company on or before March 13, 2026 without further approval or authorization of the Company’s stockholders, was approved by the stockholders by the following vote:

You can definitely make money if you can time this one right. Most of the time you will just get your nuts caught if you trade JAGX. I never seen a company dilute and then reverse split like this company does. This has to be one of the worst offenders.

DT you not jumping in on JAGX?
I don’t blame you.
In the past when i was losing a lot of money on this stock i loaded up heavily when it got to cheap and i pulled out with a nice profit.
It was a gamble but i don’t think i would do it again

I don't know who in their right mind would want to invest in this company unless they like losing money. Just unbelievable!

Did I read that right? Another stock split???

I hate to say this, but the "Shareholder Rights Plan" sounds like a complete load of bullshit.

Maybe I'm missing something.

Fair question and accurate observation.

Conte can expect the NASD 30-day deficiency notice this week. That gives her a year to play the NASD "request an extension" game before another reverse split.

I like to gamble on zombie biotechs that fail a P3 or get an FDA rejection and get hammered even though they have a drug or device that works. This one is interesting. No illusions on my part..... just starting DD and weighing the risk vs reward.

They'll get a journal publication for Crofelemer and breast cancer, IMO, but cherry-picking a failed P3 rarely convinces the FDA to approve a drug. I'm wondering about plans for another trial? Anyone know?

all information was available in the poster presentation in San Antonio, where I attended :) take care bears

onset and sustained efficacy

a larger portion of patients with breast cancer receiving crofolemer were responders for all 3 months
p value long term = 0.0123
that means 💲

patients with breast cancer showed significant improvement with crofolemer over placebo
p value = 0.0245

In a drug trial, a "good" p-value is generally considered to be less than 0.05; this means that there is less than a 5% chance that the observed results occurred by random chance, indicating a statistically significant difference between the drug and the control group.

Will this pos ever make some money for the share holders...so many pr's making no difference

This stock has been a bane to me.

No news about the partnership at the conference or after the conference....

Up 30% on 2m volume, any idea what's cookin?

This stock really got hammered the past few years.

Suspect its on a 'life support' device
hidden in a locked room.

With a couple of folks still around
with a mission of trying to figure out
how to keep the plug from being pulled.

Disclaimer: did get out with some 'gains' cause
I sold out before the news hit. And only reason
for dropping 'in' was cause I was curious to see what
was being said (and I haven't deleted the board cause
I am curious to see if they will be able to take another
run at it)

Is this thing dead now?

The market conditions are rough right now pending political events.

JAGX new 52=week low

That's why I chose to exit my position for now

Fuc k November...and F uck Conte

I think data was as expected. Look, cancer patients on TARGETED therapies have a 95% chance of getting CID. Breast and Lung cancer patients in ONTARGET received TARGETED therapies. So, if it worked on 75% of the patients. Which is the group were 95% of the patients get CID, the trial is succesfull... simple.

HOWEVER, I exited my position for the following reason: In my opinion there was not shared any detailed information, because the principal investigator wants to take the data to SABCS (breast cancer symposium), like they did with the phase 2 trial.

I've seen it with other stocks that the principal investigators prefere this. And they decide where data is presented. So in my opinion we can wait for the full data till december 9th (SABCS)

So, unless the POC data for SBS and MVIS shows up, or a a new partnership... it will be a long wait, and shorts will take it down again. That's why I chose to exit, but I will be back in november

Scam POS over 20 years endless printing shares and r/s.

WOW I was close to jump on this a few days ago...I ned a break trading these loser pennies

What your plan Shadow? You are/were a big supporter, do you think the data is good? Any chances of recovery or it’s just another ?

This CEO needs to be investigated. The RS was BS, the "imminent" publishing of data??? These have totally screwed the shareholder, and she damn well knew exactly what was happening, or this thing would have been sub penny.

For sure not a good stock at all unless around 5 cents then I can play with it. Free ATM for the CEO all they do offering dumping and RS

I was owning shares. 75% down.

Data was GOOD, as I predicted. Can't blame my own DD

Can blame management. Wtf was that for a shit show. No complete data, horrible press release. Horrible managed

I really don't think Shadow ever owned any shares. He was just here to spout lies about the results and try to get the last drop of money out of the remaining unsuspected shareholders....koddos to you shadow. Great job. This will be back to 5 cents again in no time... Another offering , another reverse split maybe they'll change their name to TIGX... Same criminals , same outcome. CEO waited till now because she's leaving for her European trip and Africa trip tomorrow. She just wanted to get the frig out of Dodge before the death threats started.

Me too. They try and BS everyone with the “we have to do this to stay in the nasdaq”. That kills the shareholder especially when like you said, it will be at a nickel again soon. Glad I got out as soon as I heard anything about a reverse split and how good it was going to be for the company and shareholders. Not even good for the company because no one has faith or trust in the controlling interests anymore.

lol idiot

right lol .... big redddddd

right lol .....

mr brains how is your account????
i knowwww biggggg redddddd

look at the pps i told you idiots

JAGX new 52 week low

So happy I got out before RS this junk one so dead years ago but I will buy some when it drops to 5 cents which it’s coming soon

Mayday!!!!

Yes, after the next reverse split! LOL

Yes, after the next reverse split! LOL